{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:09:58Z","timestamp":1790237398818,"version":"4.1.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"16","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.2217\/fon-2023-0963","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:52:30Z","timestamp":1705053150000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Brightline-2: a phase IIa\/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-8455","authenticated-orcid":false,"given":"Changhoon","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lamarca","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology & Endocrinology, Hannover Medical School, 0625 Hannover, Germany"},{"name":"Department of Gastroenterology & Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Pishvaian","sequence":"additional","affiliation":[{"name":"Department of Oncology, John Hopkins University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Goyal","sequence":"additional","affiliation":[{"name":"Stanford Cancer Center, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"M\u00e4rten","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim International GmbH, 55218 Ingelheim am Rhein, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Teufel","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 0687, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Geng","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim (China) Investment Co., Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigusa","family":"Morizane","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary & Pancreatic Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmt147"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.531"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0151"},{"key":"e_1_3_6_7_1","unstructured":"Cancer.Net. Gallbladder cancer: statistics. www.cancer.net\/cancer-types\/gallbladder-cancer\/statistics (21st May 2023)."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S157156"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.506"},{"issue":"8","key":"e_1_3_6_10_1","first-page":"EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh D-Y","year":"2022","unstructured":"Oh D-Y, Ruth He A, Qin S et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. N. Eng. J. Med. Evid. 1(8), EVIDoa2200015 (2022).","journal-title":"N. Eng. J. Med. Evid."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.007"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00573"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00486-1"},{"key":"e_1_3_6_16_1","unstructured":"Cancer.Net. Pancreatic cancer: statistics. www.cancer.net\/cancer-types\/pancreatic-cancer\/statistics#:\u223c:text=How%20many%20people%20are%20diagnosed approximately%203%25%20of%20all%20cancers (21 May 2023)."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.688377"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i2.173"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000517244"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.328"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00986-1"},{"issue":"5","key":"e_1_3_6_22_1","first-page":"603","article-title":"NCCN guidelines updates: pancreatic cancer","volume":"17","author":"Tempero MA","year":"2019","unstructured":"Tempero MA. NCCN guidelines updates: pancreatic cancer. J. Natl Compr. Canc. Netw. 17(5.5), 603\u2013605 (2019).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0017"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32517-X"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60845-X"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035807"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2019-3197"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0153"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.543"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:57:41Z","timestamp":1727215061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,6,6]]}},"alternative-id":["10.2217\/fon-2023-0963"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0963","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}